EUVIMEDEUVIMED entdecken
Multizentrische StudieValidierungsstudieOpen Access

Multicentric Assessment of a Multimorbidity-Adjusted Disability Score to Stratify Depression-Related Risks Using Temporal Disease Maps: Instrument Validation Study

Rubèn González-Colom iD, Kangkana Mitra iD, Emili Vela iD, Andras Gezsi iD, Teemu Paajanen iD, Zsófia Gál iD, Gabor Hullam iD, Hannu Mäkinen iD, Tamas Nagy iD, Mikko Kuokkanen iD, Jordi Piera-Jiménez iD, Josep Roca iD und 3 weitere

Journal of Medical Internet Research · 2024

DOI: 10.2196/53162 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Medical Internet Research, 2024. Verfasst von Rubèn González-Colom und 14 weiteren Autor:innen. Beteiligte Einrichtung: Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. Hauptthemen laut MEDLINE: Multimorbidity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Comprehensive management of multimorbidity can significantly benefit from advanced health risk assessment tools that facilitate value-based interventions, allowing for the assessment and prediction of disease progression. Our study proposes a novel methodology, the Multimorbidity-Adjusted Disability Score (MADS), which integrates disease trajectory methodologies with advanced techniques for assessing interdependencies among concurrent diseases. This approach is designed to better assess the clinical burden of clusters of interrelated diseases and enhance our ability to anticipate disease progression, thereby potentially informing targeted preventive care interventions.

Objective

This study aims to evaluate the effectiveness of the MADS in stratifying patients into clinically relevant risk groups based on their multimorbidity profiles, which accurately reflect their clinical complexity and the probabilities of developing new associated disease conditions.

Methods

In a retrospective multicentric cohort study, we developed the MADS by analyzing disease trajectories and applying Bayesian statistics to determine disease-disease probabilities combined with well-established disability weights. We used major depressive disorder (MDD) as a primary case study for this evaluation. We stratified patients into different risk levels corresponding to different percentiles of MADS distribution. We statistically assessed the association of MADS risk strata with mortality, health care resource use, and disease progression across 1 million individuals from Spain, the United Kingdom, and Finland.

Results

The results revealed significantly different distributions of the assessed outcomes across the MADS risk tiers, including mortality rates; primary care visits; specialized care outpatient consultations; visits in mental health specialized centers; emergency room visits; hospitalizations; pharmacological and nonpharmacological expenditures; and dispensation of antipsychotics, anxiolytics, sedatives, and antidepressants (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MultimorbidityHumansRetrospective StudiesFemaleMaleMiddle AgedRisk AssessmentAdultAgedSpainMajor Depressive DisorderBayes TheoremDisease ProgressionUnited KingdomDepressionFinland

Stichwörter der Autor:innen

disease trajectorieshealth risk assessmentmajor depressive disordermultimorbidity

Autor:innen und Institutionen

  • Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
  • Catalan Health Service, Barcelona, Spain.
  • Digitalization for the Sustainability of the Healthcare - Institut d'Investigació Biomèdica de Bellvitge, Barcelona, Spain.
  • Department of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest, Hungary.
  • Department of Public Health and Welfare, Finnish Health and Welfare Institute, Helsinki, Finland.
  • Department of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary.

ORCID-Profile: Rubèn González-Colom, Kangkana Mitra, Emili Vela, Andras Gezsi, Teemu Paajanen, Zsófia Gál, Gabor Hullam, Hannu Mäkinen, Tamas Nagy, Mikko Kuokkanen, Jordi Piera-Jiménez, Josep Roca, Peter Antal, Gabriella Juhasz, Isaac Cano

Zitieren

APA

González-Colom, R., Mitra, K., Vela, E., Gezsi, A., Paajanen, T., Gál, Z., Hullam, G., Mäkinen, H., Nagy, T., Kuokkanen, M., Piera-Jiménez, J., Roca, J., Antal, P., Juhasz, G., & Cano, I. (2024). Multicentric Assessment of a Multimorbidity-Adjusted Disability Score to Stratify Depression-Related Risks Using Temporal Disease Maps: Instrument Validation Study. Journal of Medical Internet Research. https://doi.org/10.2196/53162

Vancouver

González-Colom R, Mitra K, Vela E, Gezsi A, Paajanen T, Gál Z, et al. Multicentric Assessment of a Multimorbidity-Adjusted Disability Score to Stratify Depression-Related Risks Using Temporal Disease Maps: Instrument Validation Study. Journal of Medical Internet Research. 2024. doi:10.2196/53162

BibTeX
@article{GonzlezColom2024,
  author = {González-Colom, Rubèn and Mitra, Kangkana and Vela, Emili and Gezsi, Andras and Paajanen, Teemu and Gál, Zsófia and Hullam, Gabor and Mäkinen, Hannu and Nagy, Tamas and Kuokkanen, Mikko and Piera-Jiménez, Jordi and Roca, Josep and Antal, Peter and Juhasz, Gabriella and Cano, Isaac},
  title = {Multicentric Assessment of a Multimorbidity-Adjusted Disability Score to Stratify Depression-Related Risks Using Temporal Disease Maps: Instrument Validation Study},
  journal = {Journal of Medical Internet Research},
  year = {2024},
  doi = {10.2196/53162}
}
Kostenlos starten →